Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 - The Role of Natural Immunity: A Narrative Review
Sara Diani, Erika Leonardi, Attilio Cavezzi, et al.
(2022)
Open Access | Times Cited: 13

Showing 13 citing articles:

Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Paolo Bellavite, Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2023) Vol. 11, Iss. 2, pp. 451-451
Open Access | Times Cited: 29
Vitamin D Deficiency Meets Hill’s Criteria for Causation in SARS-CoV-2 Susceptibility, Complications, and Mortality: A Systematic Review
Sunil J. Wimalawansa
Nutrients (2025) Vol. 17, Iss. 3, pp. 599-599
Open Access
How Does Vaccine-Induced Immunity Compare to Infection-Acquired Immunity in the Dynamics of COVID-19?
Indunil M. Hewage, Dylan Hull-Nye, Elissa J. Schwartz
Pathogens (2025) Vol. 14, Iss. 2, pp. 179-179
Open Access
The Omicron Variant Reinfection Risk among Individuals with a Previous SARS-CoV-2 Infection within One Year in Shanghai, China: A Cross-Sectional Study
Chuchu Ye, Ge Zhang, Anran Zhang, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1146-1146
Open Access | Times Cited: 12
The coevolution of Covid-19 and host immunity
Azizul Haque, Anudeep B. Pant
Exploration of Medicine (2024), pp. 167-184
Open Access | Times Cited: 2
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins
Evgeniia N. Bykonia, Denis A. Kleymenov, Vladimir А. Gushchin, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 379-379
Open Access | Times Cited: 1
Clinical Severity in Different Waves of SARS-CoV-2 Infection in Sicily: A Model of Smith’s “Law of Declining Virulence” from Real-World Data
Emanuele Amodio, Dario Genovese, Alessandra Fallucca, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 125-125
Open Access | Times Cited: 8
COVID-19-Related Age Profiles for SARS-CoV-2 Variants in England and Wales and States of the USA (2020 to 2022): Impact on All-Cause Mortality
Rod Jones, Andrey Ponomarenko
Infectious Disease Reports (2023) Vol. 15, Iss. 5, pp. 600-634
Open Access | Times Cited: 4
Persistence of T-Cell Immunity Responses against SARS-CoV-2 for over 12 Months Post COVID-19 Infection in Unvaccinated Individuals with No Detectable IgG Antibodies
Vassiliki Pitiriga, Myrto Papamentzelopoulou, Kanella E. Konstantinakou, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1764-1764
Open Access | Times Cited: 4
Persistence of SARS-CoV-2 IgG Antibody Response among South African Adults: A Prospective Cohort Study
Oladele Vincent Adeniyi, Oyewole Christopher Durojaiye, Charity Masilela
Vaccines (2023) Vol. 11, Iss. 6, pp. 1068-1068
Open Access | Times Cited: 3
The Changing Trajectory of Covid-19 and How Immunity is Evolving with It
Azizul Haque, Anudeep B. Pant
(2023)
Open Access | Times Cited: 1
Will Omics Biotechnologies Save Us from Future Pandemics? Lessons from COVID-19 for Vaccinomics and Adversomics
Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2022) Vol. 11, Iss. 1, pp. 52-52
Open Access | Times Cited: 2
Page 1

Scroll to top